Daxing Xie

6PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2024
Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).

Daxing Xie, Jie Shen, Jianping Gong

|Jun 24, 2024
Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).

Daxing Xie, Jie Shen, Jianping Gong

|May 07, 2024
Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).

Daxing Xie, Jie Shen, Liang Liu

|Jun 30, 2022
YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer.

Jie Shen, Qingwen Huang, Weiyi Jia

|May 31, 2022
Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.

Dayong Zhao, Jiao Deng, Beibei Cao

|Jul 03, 2018
Detection of carcinoembryonic antigen in peritoneal fluid of patients undergoing laparoscopic distal gastrectomy with complete mesogastric excision.

D Xie, Y Wang, J Shen

Pageof 1

Frequent Collaborators